Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia
Authors
Keywords
Levodopa, Deep Brain Stimulation, Pramipexole, Ropinirole, Rotigotine
Journal
DRUGS
Volume 76, Issue 7, Pages 759-777
Publisher
Springer Nature
Online
2016-04-18
DOI
10.1007/s40265-016-0566-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Movement disorders induced by deep brain stimulation
- (2016) José Fidel Baizabal-Carvallo et al. PARKINSONISM & RELATED DISORDERS
- Dual κ-agonist/μ-antagonist opioid receptor modulation reduces levodopa-induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model of Parkinson disease
- (2015) Lisa F. Potts et al. ANNALS OF NEUROLOGY
- Neurobiology of l-DOPA induced dyskinesia and the novel therapeutic strategies
- (2015) Sabeena Sharma et al. BIOMEDICINE & PHARMACOTHERAPY
- Abnormal dopaminergic modulation of striato-cortical networks underlies levodopa-induced dyskinesias in humans
- (2015) Damian M. Herz et al. BRAIN
- Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson’s disease: a dose-finding study
- (2015) Per Svenningsson et al. BRAIN
- A Randomized Controlled Trial of Subcutaneous Apomorphine for Parkinson Disease
- (2015) Masahiro Nomoto et al. CLINICAL NEUROPHARMACOLOGY
- The efficacy of oral adenosine A2Aantagonist istradefylline for the treatment of moderate to severe Parkinson’s disease
- (2015) Ruxandra Julia Vorovenci et al. Expert Review of Neurotherapeutics
- Advances in functional neurosurgery for Parkinson's disease
- (2015) Leo Verhagen Metman et al. MOVEMENT DISORDERS
- Zonisamide improves wearing-off in Parkinson's disease: A randomized, double-blind study
- (2015) Miho Murata et al. MOVEMENT DISORDERS
- Clinical and scientific perspectives on movement disorders: Stanley Fahn's contributions
- (2015) Joseph Jankovic et al. MOVEMENT DISORDERS
- New treatments for levodopa-induced motor complications
- (2015) Olivier Rascol et al. MOVEMENT DISORDERS
- Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)
- (2015) Rajesh Pahwa et al. MOVEMENT DISORDERS
- The therapeutic potential of cannabinoids for movement disorders
- (2015) Benzi Kluger et al. MOVEMENT DISORDERS
- Levodopa alone compared with levodopa-sparing therapy as initial treatment for Parkinson’s disease: a meta-analysis
- (2015) Cheng-long Xie et al. NEUROLOGICAL SCIENCES
- Serotonin/dopamine transporter ratio as a predictor of l-dopa–induced dyskinesia
- (2015) Philippe Huot et al. NEUROLOGY
- Respiratory dyskinesia in a patient with Parkinson disease successfully treated with STN DBS
- (2015) Tao Xie et al. NEUROLOGY
- Putaminal serotonergic innervation
- (2015) Jee-Young Lee et al. NEUROLOGY
- Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease
- (2015) D. Calandrella et al. NEUROLOGY
- Dyskinesias and impulse control disorders in Parkinson's disease: From pathogenesis to potential therapeutic approaches
- (2015) Haritz Jiménez-Urbieta et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease – Clinical practice recommendations
- (2015) Claudia Trenkwalder et al. PARKINSONISM & RELATED DISORDERS
- Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes
- (2015) Angelo Antonini et al. PARKINSONISM & RELATED DISORDERS
- Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
- (2015) Matthieu F. Bastide et al. PROGRESS IN NEUROBIOLOGY
- Effect of Subthalamic Deep Brain Stimulation on Levodopa-Induced Dyskinesia in Parkinson's Disease
- (2015) Ji Hee Kim et al. YONSEI MEDICAL JOURNAL
- Risk of Disabling Response Fluctuations and Dyskinesias for Dopamine Agonists Versus Levodopa in Parkinson’s Disease1
- (2015) Charlotte A. Haaxma et al. Journal of Parkinsons Disease
- The efficacy of oral adenosine A2Aantagonist istradefylline for the treatment of moderate to severe Parkinson’s disease
- (2015) Ruxandra Julia Vorovenci et al. Expert Review of Neurotherapeutics
- Therapeutic strategies to prevent and manage dyskinesias in Parkinson’s disease
- (2014) Manuela Pilleri et al. Expert Opinion On Drug Safety
- Evaluation of the Efficacy of Pramipexole for Treating Levodopa-induced Dyskinesia in Patients with Parkinson's Disease
- (2014) Hiroya Utsumi et al. INTERNAL MEDICINE
- Low-frequency repetitive transcranial magnetic stimulation for dyskinesia and motor performance in Parkinson’s disease
- (2014) Sevgi Sayın et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial
- (2014) PD MED Collaborative Group LANCET
- Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial
- (2014) Robert A Hauser et al. LANCET NEUROLOGY
- Novel formulations and modes of delivery of levodopa
- (2014) Werner Poewe et al. MOVEMENT DISORDERS
- The medical treatment of Parkinson disease from James Parkinson to George Cotzias
- (2014) Stanley Fahn MOVEMENT DISORDERS
- Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease
- (2014) Rupam Borgohain et al. MOVEMENT DISORDERS
- Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics
- (2014) Peter A. LeWitt MOVEMENT DISORDERS
- Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease
- (2014) J. Y. Hong et al. NEUROLOGY
- Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology
- (2014) B. S. Koppel et al. NEUROLOGY
- Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s disease
- (2014) E. Tronci et al. NEUROSCIENCE
- Randomized clinical trial of topiramate for levodopa-induced dyskinesia in Parkinson's disease
- (2014) Christopher Kobylecki et al. PARKINSONISM & RELATED DISORDERS
- Effects of long-term treatment with rotigotine transdermal system on dyskinesia in patients with early-stage Parkinson's disease
- (2014) Nir Giladi et al. PARKINSONISM & RELATED DISORDERS
- Comparing clinical features of young onset, middle onset and late onset Parkinson's disease
- (2014) Raja Mehanna et al. PARKINSONISM & RELATED DISORDERS
- An Eight-Year Clinic Experience with Clozapine Use in a Parkinson’s Disease Clinic Setting
- (2014) Nawaz Hack et al. PLoS One
- Parkinson Disease Subtypes
- (2014) Mary Ann Thenganatt et al. JAMA Neurology
- New treatments for the motor symptoms of Parkinson’s disease
- (2014) Anne-Catherine Vijverman et al. Expert Review of Clinical Pharmacology
- Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial
- (2013) Robert A Hauser et al. LANCET NEUROLOGY
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
- (2013) C Warren Olanow et al. LANCET NEUROLOGY
- Ropinirole monotherapy induced severe reversible dyskinesias in Parkinson's disease
- (2013) Amit Batla et al. MOVEMENT DISORDERS
- Adenosine A2Areceptor antagonist istradefylline reduces daily OFF time in Parkinson's disease
- (2013) Yoshikuni Mizuno et al. MOVEMENT DISORDERS
- Which dyskinesia scale best detects treatment response?
- (2013) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Caffeine consumption and risk of dyskinesia in CALM-PD
- (2013) Anne-Marie A. Wills et al. MOVEMENT DISORDERS
- Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia
- (2013) Erwan Bezard et al. MOVEMENT DISORDERS
- Withdrawing amantadine in dyskinetic patients with Parkinson disease: The AMANDYSK trial
- (2013) F. Ory-Magne et al. NEUROLOGY
- Levodopa–carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results
- (2013) Hubert H. Fernandez et al. PARKINSONISM & RELATED DISORDERS
- Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease
- (2013) Rajesh Pahwa et al. PARKINSONISM & RELATED DISORDERS
- Cortical Effects of Deep Brain Stimulation
- (2013) Qian Li et al. JAMA Neurology
- Targeting Glutamate Receptors to Tackle the Pathogenesis, Clinical Symptoms and Levodopa-Induced Dyskinesia Associated with Parkinson’s Disease
- (2012) Susan Duty CNS DRUGS
- New insights into the mechanism of drug-induced dyskinesia
- (2012) Anton J. M. Loonen et al. CNS SPECTRUMS
- Therapies in Parkinsonʼs disease
- (2012) Joseph Jankovic et al. CURRENT OPINION IN NEUROLOGY
- Anti-dyskinetic mechanisms of amantadine and dextromethorphan in the 6-OHDA rat model of Parkinson’s disease: role of NMDA vs. 5-HT1A receptors
- (2012) Melanie A. Paquette et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Are high doses of carbidopa a concern? A randomized, clinical trial in Parkinson's disease
- (2012) Lissa S. Brod et al. MOVEMENT DISORDERS
- Poster Presentations
- (2012) MOVEMENT DISORDERS
- Randomized clinical trial of fipamezole for dyskinesia in Parkinson disease (FJORD study)
- (2012) P. A. LeWitt et al. NEUROLOGY
- GPi and STN deep brain stimulation can suppress dyskinesia in Parkinson's disease
- (2012) Genko Oyama et al. PARKINSONISM & RELATED DISORDERS
- Pardoprunox as adjunct therapy to levodopa in patients with Parkinson’s disease experiencing motor fluctuations: Results of a double-blind, randomized, placebo-controlled, trial
- (2012) O. Rascol et al. PARKINSONISM & RELATED DISORDERS
- Cost analysis of the treatments for patients with advanced Parkinson's disease: SCOPE study
- (2012) Francesc Valldeoriola et al. JOURNAL OF MEDICAL ECONOMICS
- Therapies for dopaminergic-induced dyskinesias in parkinson disease
- (2011) Mildred D. Gottwald et al. ANNALS OF NEUROLOGY
- Patient Diaries As a Clinical Endpoint in Parkinson's Disease Clinical Trials
- (2011) Spyridon Spyros Papapetropoulos CNS Neuroscience & Therapeutics
- Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders
- (2011) Joseph Jankovic et al. Expert Review of Neurotherapeutics
- Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial
- (2011) Robert A Hauser et al. LANCET NEUROLOGY
- Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double-blind trials
- (2011) Cristina Sampaio et al. MOVEMENT DISORDERS
- The motor phenotype of Parkinson's disease in relation to age at onset
- (2011) Mirdhu M. Wickremaratchi et al. MOVEMENT DISORDERS
- Health-related quality-of-life scales in Parkinson's disease: Critique and recommendations
- (2011) Pablo Martinez-Martin et al. MOVEMENT DISORDERS
- Unilateral GPi-DBS as a Treatment for Levodopa-Induced Respiratory Dyskinesia in Parkinson Disease
- (2011) Genko Oyama et al. NEUROLOGIST
- Calcium-permeable AMPA receptors are involved in the induction and expression of l-DOPA-induced dyskinesia in Parkinson’s disease
- (2010) Christopher Kobylecki et al. JOURNAL OF NEUROCHEMISTRY
- Long-term antidyskinetic efficacy of amantadine in Parkinson's disease
- (2010) Elisabeth Wolf et al. MOVEMENT DISORDERS
- Levetiracetam for the management of levodopa-induced dyskinesias in Parkinson's disease
- (2010) P. Stathis et al. MOVEMENT DISORDERS
- Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease
- (2010) Ray L. Watts et al. MOVEMENT DISORDERS
- Camptocormia, head drop and other bent spine syndromes: Heterogeneous etiology and pathogenesis of Parkinsonian deformities
- (2010) Joseph Jankovic MOVEMENT DISORDERS
- Differential genetic susceptibility in diphasic and peak-dose dyskinesias in Parkinson's disease
- (2010) Jee-Young Lee et al. MOVEMENT DISORDERS
- Pallidal versus Subthalamic Deep-Brain Stimulation for Parkinson's Disease
- (2010) Kenneth A. Follett et al. NEW ENGLAND JOURNAL OF MEDICINE
- Classifying risk factors for dyskinesia in Parkinson’s disease
- (2010) J.C. Sharma et al. PARKINSONISM & RELATED DISORDERS
- Long-term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease
- (2009) ARCHIVES OF NEUROLOGY
- Safety and Tolerability of Pardoprunox, a New Partial Dopamine Agonist, in a Randomized, Controlled Study of Patients with Advanced Parkinson’s Disease
- (2009) R.A. Hauser et al. EUROPEAN NEUROLOGY
- Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia
- (2008) Joohyung Lee et al. BRAIN
- Levodopa-Induced Dyskinesias in Parkinson’s Disease: Etiology, Impact on Quality of Life, and Treatments
- (2008) Elmyra V. Encarnacion et al. EUROPEAN NEUROLOGY
- Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and parkinsonism
- (2008) John G. Nutt et al. MOVEMENT DISORDERS
- Nicotine and Parkinson's disease: Implications for therapy
- (2008) Maryka Quik et al. MOVEMENT DISORDERS
- Repetitive transcranial magnetic stimulation for levodopa-induced dyskinesias in Parkinson's disease
- (2008) Saša R. Filipović et al. MOVEMENT DISORDERS
- Adenosine and its receptors: Multiple modulatory functions and potential therapeutic targets for neurologic disease
- (2008) E. E. Benarroch NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started